{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:12:45Z","timestamp":1715955165450},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T00:00:00Z","timestamp":1393286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40291-014-0092-5","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T05:32:20Z","timestamp":1393219940000},"page":"419-426","source":"Crossref","is-referenced-by-count":5,"title":["Association of Rho-kinase 1 (ROCK1) Gene Polymorphisms with Beh\u00e7et\u2019s Disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Elif","family":"Oguz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah Tuncay","family":"Demiry\u00fcrek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavuz","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fcnyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esma","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Oztuzcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belgin","family":"Alasehirli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,25]]},"reference":[{"issue":"6","key":"92_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11926-010-0132-z","volume":"12","author":"Y Yazici","year":"2010","unstructured":"Yazici Y, Yurdakul S, Yazici H. Beh\u00e7et\u2019s syndrome. Curr Rheumatol Rep. 2010;12(6):429\u201335.","journal-title":"Curr Rheumatol Rep."},{"issue":"4","key":"92_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2796.1996.396853000.x","volume":"240","author":"IC Haznedaroglu","year":"1996","unstructured":"Haznedaroglu IC, Ozcebe OI, Ozdemir O, et al. Impaired haemostatic kinetics and endothelial function in Beh\u00e7et\u2019s disease. J Intern Med. 1996;240(4):181\u20137.","journal-title":"J Intern Med."},{"issue":"2","key":"92_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0049-3848(02)00006-3","volume":"105","author":"S Kiraz","year":"2002","unstructured":"Kiraz S, Ertenli I, Ozt\u00fcrk MA, et al. Pathological haemostasis and \u201cprothrombotic state\u201d in Beh\u00e7et\u2019s disease. Thromb Res. 2002;105(2):125\u201333.","journal-title":"Thromb Res."},{"issue":"4","key":"92_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/0003319710382417","volume":"62","author":"N Acikgoz","year":"2011","unstructured":"Acikgoz N, Ermi\u015f N, Ya\u011fmur J, et al. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Beh\u00e7et disease. Angiology. 2011;62(4):296\u2013300.","journal-title":"Angiology."},{"issue":"8697","key":"92_CR5","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet."},{"issue":"1","key":"92_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03857.x","volume":"156","author":"MT Keogan","year":"2009","unstructured":"Keogan MT. Clinical \u0131mmunology review series: an approach to the patient with recurrent orogenital ulceration, including Beh\u00e7et\u2019s syndrome. Clin Exp Immunol. 2009;156(1):1\u201311.","journal-title":"Clin Exp Immunol."},{"issue":"4","key":"92_CR7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","volume":"9","author":"C Mendoza-Pinto","year":"2010","unstructured":"Mendoza-Pinto C, Garc\u00eda-Carrasco M, Jim\u00e9nez-Hern\u00e1ndez M, et al. Etiopathogenesis of Behcet\u2019s disease. Autoimmun Rev. 2010;9(4):241\u20135.","journal-title":"Autoimmun Rev."},{"issue":"8","key":"92_CR8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/j.1460-2075.1996.tb00539.x","volume":"15","author":"T Ishizaki","year":"1996","unstructured":"Ishizaki T, Maekawa M, Fujisawa K, et al. The small GTP-binding protein Rho binds to and activates a 160\u00a0kDa Ser\/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 1996;15(8):1885\u201393.","journal-title":"EMBO J."},{"issue":"9","key":"92_CR9","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/j.1460-2075.1996.tb00574.x","volume":"15","author":"T Matsui","year":"1996","unstructured":"Matsui T, Amano M, Yamamoto T, et al. Rho-associated kinase, a novel serine\/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996;15(9):2208\u201316.","journal-title":"EMBO J."},{"issue":"6","key":"92_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","volume":"4","author":"K Riento","year":"2003","unstructured":"Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003;4(6):446\u201356.","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"4","key":"92_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/0975-3583.74258","volume":"1","author":"L Yao","year":"2010","unstructured":"Yao L, Romero MJ, Toque HA, et al. The role of RhoA\/Rho kinase pathway in endothelial dysfunction. J Cardiovasc Dis Res. 2010;1(4):165\u201370.","journal-title":"J Cardiovasc Dis Res."},{"issue":"3","key":"92_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2010.12.006","volume":"32","author":"Q Zhou","year":"2011","unstructured":"Zhou Q, Gensch C, Liao JK. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci. 2011;32(3):167\u201373.","journal-title":"Trends Pharmacol Sci."},{"issue":"4\u20135","key":"92_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1537-1891(03)00008-9","volume":"39","author":"B Wojciak-Stothard","year":"2002","unstructured":"Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol. 2002;39(4\u20135):187\u201399.","journal-title":"Vascul Pharmacol."},{"issue":"5","key":"92_CR14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/01.ATV.21.5.868","volume":"21","author":"K Takeda","year":"2001","unstructured":"Takeda K, Ichiki T, Tokunou T, et al. Critical role of Rho-kinase and MEK\/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol. 2001;21(5):868\u201373.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"8","key":"92_CR15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","volume":"93","author":"M Higashi","year":"2003","unstructured":"Higashi M, Shimokawa H, Hattori T, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res. 2003;93(8):767\u201375.","journal-title":"Circ Res."},{"issue":"24","key":"92_CR16","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.22.24.8467-8477.2002","volume":"22","author":"XF Ming","year":"2002","unstructured":"Ming XF, Viswambharan H, Barandier C, et al. Rho GTPase\/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B\/Akt in human endothelial cells. Mol Cell Biol. 2002;22(24):8467\u201377.","journal-title":"Mol Cell Biol."},{"issue":"12","key":"92_CR17","first-page":"3702","volume":"41","author":"N Mizuki","year":"2000","unstructured":"Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Beh\u00e7et\u2019s disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41(12):3702\u20138.","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"1","key":"92_CR18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1529-0131(200101)44:1<239::AID-ANR31>3.0.CO;2-X","volume":"44","author":"A G\u00fcl","year":"2001","unstructured":"G\u00fcl A, Hajeer AH, Worthington J, et al. Evidence for linkage of the HLA-B locus in Beh\u00e7et\u2019s disease, obtained using the transmission disequilibrium test. Arthritis Rheum. 2001;44(1):239\u201340.","journal-title":"Arthritis Rheum."},{"issue":"6","key":"92_CR19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.trsl.2012.08.002","volume":"160","author":"E Oguz","year":"2012","unstructured":"Oguz E, Alasehirli B, Pehlivan Y, et al. Association between Rho-kinase (ROCK2) gene polymorphisms and Beh\u00e7et\u2019s disease. Transl Res. 2012;160(6):428\u201334.","journal-title":"Transl Res."},{"issue":"3","key":"92_CR20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"92_CR21","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/art.21060","volume":"52","author":"J Karasneh","year":"2005","unstructured":"Karasneh J, G\u00fcl A, Ollier WE, et al. Whole-genome screening for susceptibility genes in multicase families with Beh\u00e7et\u2019s disease. Arthritis Rheum. 2005;52(6):1836\u201342.","journal-title":"Arthritis Rheum."},{"issue":"3","key":"92_CR22","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar2695","volume":"11","author":"Y Fei","year":"2009","unstructured":"Fei Y, Webb R, Cobb BL, et al. Identification of novel genetic susceptibility loci for Beh\u00e7et\u2019s disease using a genome-wide association study. Arthritis Res Ther. 2009;11(3):R66.","journal-title":"Arthritis Res Ther."},{"issue":"8","key":"92_CR23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet. 2010;42(8):698\u2013702.","journal-title":"Nat Genet."},{"issue":"9","key":"92_CR24","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1982.01030040433013","volume":"100","author":"S Ohno","year":"1982","unstructured":"Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Beh\u00e7et\u2019s disease. Arch Ophthalmol. 1982;100(9):1455\u20138.","journal-title":"Arch Ophthalmol."},{"issue":"2","key":"92_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/keq331","volume":"50","author":"M Piga","year":"2011","unstructured":"Piga M, Mathieu A. Genetic susceptibility to Behcet\u2019s disease: role of genes belonging to the MHC region. Rheumatology (Oxford). 2011;50(2):299\u2013310.","journal-title":"Rheumatology (Oxford)."},{"key":"92_CR26","first-page":"912589","volume":"2012","author":"T\u0130 Kaya","year":"2012","unstructured":"Kaya T\u0130. Genetics of Beh\u00e7et\u2019s disease. Patholog Res Int. 2012;2012:912589.","journal-title":"Patholog Res Int."},{"key":"92_CR27","doi-asserted-by":"crossref","unstructured":"Palomino Doza J, Topf A, Bentham J, et al. Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to Tetralogy of Fallot. BMC Genet. 2013;14:57.","DOI":"10.1186\/1471-2156-14-57"},{"issue":"3","key":"92_CR28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000341395","volume":"80","author":"I Sari","year":"2013","unstructured":"Sari I, Berberoglu B, Ozkara E, et al. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. Pathobiology. 2013;80(3):138\u201345.","journal-title":"Pathobiology."},{"issue":"4","key":"92_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","volume":"50","author":"C Evereklioglu","year":"2005","unstructured":"Evereklioglu C. Current concepts in the etiology and treatment of Beh\u00e7et disease. Surv Ophthalmol. 2005;50(4):297\u2013350.","journal-title":"Surv Ophthalmol."},{"issue":"2","key":"92_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1468-3083.2005.01075.x","volume":"19","author":"S Bekpinar","year":"2005","unstructured":"Bekpinar S, Kili\u00e7 N, Unl\u00fc\u00e7er\u00e7i Y, et al. Evaluation of nitrosative and oxidative stress in Beh\u00e7et disease. J Eur Acad Dermatol Venereol. 2005;19(2):167\u201371.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"92_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-9255-9-13","volume":"9","author":"YD Akcay","year":"2012","unstructured":"Akcay YD, Sagin FG, Aksu K, et al. A panel of oxidative stress assays does not provide supplementary diagnostic information in Behcet\u2019s disease patients. J Inflamm (Lond). 2012;9:13.","journal-title":"J Inflamm (Lond)."},{"issue":"3","key":"92_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/15569527.2011.554480","volume":"30","author":"E Onur","year":"2011","unstructured":"Onur E, Kabaroglu C, Inanir I, et al. Oxidative stress impairs endothelial nitric oxide levels in Beh\u00e7et\u2019s disease. Cutan Ocul Toxicol. 2011;30(3):217\u201320.","journal-title":"Cutan Ocul Toxicol."},{"issue":"4","key":"92_CR33","doi-asserted-by":"crossref","first-page":"H1495","DOI":"10.1152\/ajpheart.01006.2003","volume":"287","author":"L Jin","year":"2004","unstructured":"Jin L, Ying Z, Webb RC. Activation of Rho\/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol. 2004;287(4):H1495\u2013500.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"2","key":"92_CR34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/hy0202.103271","volume":"39","author":"C Kataoka","year":"2002","unstructured":"Kataoka C, Egashira K, Inoue S, et al. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension. 2002;39(2):245\u201350.","journal-title":"Hypertension."},{"issue":"1\u20132","key":"92_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11010-006-2679-6","volume":"283","author":"DI Shah","year":"2006","unstructured":"Shah DI, Singh M. Involvement of Rho-kinase in experimental vascular endothelial dysfunction. Mol Cell Biochem. 2006;283(1\u20132):191\u20139.","journal-title":"Mol Cell Biochem."},{"issue":"11","key":"92_CR36","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1046\/j.1365-4362.2003.01688.x","volume":"42","author":"M Cekmen","year":"2003","unstructured":"Cekmen M, Evereklioglu C, Er H, et al. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Beh\u00e7et\u2019s syndrome. Int J Dermatol. 2003;42(11):870\u20135.","journal-title":"Int J Dermatol."},{"issue":"8","key":"92_CR37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00296-004-0484-7","volume":"25","author":"F Erdem","year":"2005","unstructured":"Erdem F, G\u00fcndo\u011fdu M, Kiki I, et al. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Beh\u00e7et\u2019s disease. Rheumatol Int. 2005;25(8):599\u2013603.","journal-title":"Rheumatol Int."},{"issue":"3","key":"92_CR38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10739680600556944","volume":"13","author":"H Sun","year":"2006","unstructured":"Sun H, Breslin JW, Zhu J, et al. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation. 2006;13(3):237\u201347.","journal-title":"Microcirculation."},{"key":"92_CR39","doi-asserted-by":"crossref","unstructured":"van Nieuw Amerongen GP, Koolwijk P, Versteilen A, et al. Involvement of RhoA\/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol. 2003;23(2):211\u20137.","DOI":"10.1161\/01.ATV.0000054198.68894.88"},{"key":"92_CR40","doi-asserted-by":"crossref","unstructured":"Zierhut M, Abu El-Asrar AM, Bodaghi B, et al. Therapy of ocular Beh\u00e7et disease. Ocul Immunol Inflamm. 2014;22(1):64\u201376.","DOI":"10.3109\/09273948.2013.866257"},{"issue":"17","key":"92_CR41","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2165\/11641370-000000000-00000","volume":"72","author":"SR Dalvi","year":"2012","unstructured":"Dalvi SR, Yildirim R, Yazici Y. Behcet\u2019s syndrome. Drugs. 2012;72(17):2223\u201341.","journal-title":"Drugs."},{"issue":"2","key":"92_CR42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbrc.2007.01.024","volume":"354","author":"NM Rubenstein","year":"2007","unstructured":"Rubenstein NM, Callahan JA, Lo DH, et al. Selective glucocorticoid control of Rho kinase isoforms regulate cell-cell interactions. Biochem Biophys Res Commun. 2007;354(2):603\u20137.","journal-title":"Biochem Biophys Res Commun."}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-014-0092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-014-0092-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-014-0092-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T18:31:50Z","timestamp":1565202710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-014-0092-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,25]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["92"],"URL":"https:\/\/doi.org\/10.1007\/s40291-014-0092-5","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,25]]}}}